Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomics in diagnostic neuropathology.

Mahlon D Johnson1, John L Floyd, Richard M Caprioli

  • 1Department of Pathology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.

Journal of Neuropathology and Experimental Neurology
|September 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

B cell expression of an enzymatic intermediary in ether lipid biosynthesis promotes antibody responses and germinal center size.

eLife·2026
Same author

Advanced Dimensionality Reduction for Imaging Mass Spectrometry of Human Eye Tissue through Low-Rank Modeling with Sparse and Dense Residuals.

Analytical chemistry·2025
Same author

LRRK2 kinase activity regulates Parkinson's disease-relevant lipids at the lysosome.

Molecular neurodegeneration·2025
Same author

A lipid atlas of the human kidney.

Science advances·2025
Same author

B cell expression of the enzyme PexRAP, an intermediary in ether lipid biosynthesis, promotes antibody responses and germinal center size.

bioRxiv : the preprint server for biology·2024
Same author

Thermal Denaturation of Fresh Frozen Tissue Enhances Mass Spectrometry Detection of Peptides.

Analytical chemistry·2024
Same journal

An unusual extra-axial supratentorial presentation of atypical teratoid/rhabdoid tumor in a child.

Journal of neuropathology and experimental neurology·2026
Same journal

Primary intracranial sarcoma, DICER1-mutant: 5 cases highlighting variable clinical and molecular features.

Journal of neuropathology and experimental neurology·2026
Same journal

Novel YWHAE-NTRK3 fusion in a pediatric glioma.

Journal of neuropathology and experimental neurology·2026
Same journal

Comprehensive clinicomolecular characterization of a methylation-defined supratentorial high-grade astrocytoma with piloid features in a young adult with confirmed germline NF1 mutation.

Journal of neuropathology and experimental neurology·2026
Same journal

Spatial mapping, isolation, and culture of primary human microglia and astrocytes: A systematic review and framework for glial cell-based models.

Journal of neuropathology and experimental neurology·2026
Same journal

Multiparameter flow cytometry of CSF identifies elevated CD8+ effector memory and TEMRA T-cells in immune-mediated neurologic disorders.

Journal of neuropathology and experimental neurology·2026
See all related articles

Imaging mass spectrometry (IMS) analyzes tissue proteomes to identify unique protein signatures. These signatures offer diagnostic and prognostic value for nervous system diseases, aiding in disease understanding and treatment assessment.

Area of Science:

  • Proteomics
  • Biomedical Imaging
  • Neuroscience

Background:

  • The post-genomic era focuses on the proteome for diagnostic and prognostic insights.
  • Advancements in imaging mass spectrometry (IMS) enable detailed proteomic analysis of tissue sections.

Purpose of the Study:

  • To explore the utility of IMS in identifying diagnostic and prognostic protein signatures.
  • To assess the potential of proteomic signatures in understanding disease progression and treatment response in nervous system disorders.

Main Methods:

  • Utilizing matrix-assisted laser desorption ionization-mass spectrometry (MALDI-MS) for protein signal acquisition.
  • Generating molecular weight images (ion density maps) from specific tissue areas.
  • Systematic investigation of protein signals within a defined molecular weight range (2,000–100,000+).

Related Experiment Videos

Main Results:

  • Identification of unique protein changes, termed "protein signatures," within tissue sections.
  • Demonstration of the diagnostic and prognostic value of these protein signatures.
  • Potential for assessing disease progression and therapeutic responses through proteomic analysis.

Conclusions:

  • Proteomic techniques, including IMS, are valuable tools for nervous system disease research.
  • Protein signatures can refine disease subclassifications and elucidate pathogenesis.
  • Integration with histology and genetic analyses enhances understanding of central and peripheral nervous system diseases.